Top Pharma Companies in India by Market Cap

Nectar Lifesciences has informed that the board of directors of the company in their meeting held on Monday, March 02, 2026, have, noted, decided and approved the following matters: 1. To acquire 100% paid- up equity share capital of Avensis Exports (‘AEPL’). 2. Change in Registrar and Share Transfer Agent (‘RTA’) of the Company from KFin Technologies (‘KFIN’) to Alankit Assignments (‘AAL’). KFIN will continue to serve as the Company’s RTA until the completion of data transition, shifting of electronic connectivity, and other related procedures, along with receipt of necessary confirmations from NSDL and CDSL. The formalities for change of RTA including documentation, execution of agreement, shifting of electronic connectivity and transition of data will be done by the Company in due course. The details as required under LODR Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, and as amended upto date, are provided in: 1. Annexure A for Acquiring 100% paid- up equity share capital of AEPL; and 2. Annexure B for change in RTA from KFIN to AAL. The Board Meeting commenced at 04:00 pm IST and concluded at 04:30 pm IST.

The above information is a part of company’s filings submitted to BSE.

Unichem Laboratories has informed that it enclosed the Postal Ballot Notice (‘Notice’) together with the explanatory statement seeking the approval of the members of the Company on the following Special Business items as set out in the Notice dated 5th February 2026: 1. Special resolution for approval of appointment of Dr. (Ms) Swati Patankar (DIN 06594600) as a Non-Executive Independent Director for a term of five years with effect from 5th February 2026. 2. Ordinary resolution for approval of material related party transaction(s) between Ipca Laboratories (‘Ipca’), holding company of Unichem Laboratories (‘Unichem’) and Unichem Pharmaceuticals USA Inc. (‘Unichem USA’), wholly owned subsidiary of Unichem. 3. Ordinary resolution for approval of material related party transaction(s) with Unichem USA, wholly owned subsidiary of Unichem. Notice is being sent through electronic mode to those members whose e-mail addresses are registered with the Company/Depositories and whose names are recorded in the Register of Members of the Company or in the Register of Beneficial Owners maintained by the Depositories as on Friday, 20th February 2026. The notice is being sent by e-mail on 25th February 2026 to the members who have registered their e-mail IDs with Depository Participant(s) or with the Company. E-voting period will commence from Thursday, 26th February 2026, IST at 9.00 am and will end on Friday, 27th March 2026 IST at 5.00 pm. The Notice will also be available on the website of the Company at www.unichemlabs.com and on the website of the National Securities Depository (NSDL) at https://www.evoting.nsdl.com.

The above information is a part of company’s filings submitted to BSE.